|
C7ORF60 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.649600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.188600E-01 |
| Normal-vs-Stage2 |
6.835400E-01 |
| Normal-vs-Stage3 |
6.175000E-01 |
| Normal-vs-Stage4 |
2.342600E-01 |
| Stage1-vs-Stage2 |
3.399800E-01 |
| Stage1-vs-Stage3 |
3.188600E-01 |
| Stage1-vs-Stage4 |
1.810390E-02 |
| Stage2-vs-Stage3 |
9.258800E-01 |
| Stage2-vs-Stage4 |
5.772800E-01 |
| Stage3-vs-Stage4 |
6.655200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.167800E-01 |
| Normal-vs-AfricanAmerican |
4.521200E-01 |
| Normal-vs-Asian |
4.848400E-01 |
| Caucasian-vs-AfricanAmerican |
3.741000E-01 |
| Caucasian-vs-Asian |
5.273000E-01 |
| AfricanAmerican-vs-Asian |
2.081800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.298800E-01 |
| Normal-vs-Female |
9.106400E-01 |
| Male-vs-Female |
9.064000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.383600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.778800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.811600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.099990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.563600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.472200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.017560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.860000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.309700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.149820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.451200E-01 |
| Normal-vs-Grade 2 |
3.890400E-01 |
| Normal-vs-Grade 3 |
3.209800E-01 |
| Normal-vs-Grade 4 |
7.612400E-02 |
| Grade 1-vs-Grade 2 |
3.405600E-01 |
| Grade 1-vs-Grade 3 |
1.705620E-02 |
| Grade 1-vs-Grade 4 |
6.340800E-03 |
| Grade 2-vs-Grade 3 |
2.169700E-02 |
| Grade 2-vs-Grade 4 |
3.323900E-03 |
| Grade 3-vs-Grade 4 |
1.584380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.211400E-01 |
| Normal-vs-ccB subtype |
8.879800E-01 |
| ccA subtype-vs-ccB subtype |
2.992000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.926200E-01 |
| Normal-vs-N1 |
7.853200E-01 |
| N0-vs-N1 |
7.830200E-01 |
|
|
